Lantern Pharma Inc.LTRNNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+4.1%
5Y CAGR+12.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+4.1%/yr
vs +49.9%/yr prior
5Y CAGR
+12.4%/yr
Recent deceleration
Acceleration
-45.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
7 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$6.58M+8.0%
2024$6.09M+1.8%
2023$5.98M+2.6%
2022$5.83M+16.1%
2021$5.02M+37.0%
2020$3.66M+148.5%
2019$1.48M+27.8%
2018$1.15M-